Bringing the Freezing of Biopharmaceuticals in From the Cold
Posted on March 15, 2021
59.4% of manufactured biopharmaceuticals are shipped in a frozen state. Add to this the COVID-19 response requiring a truly global manufacturing supply chain where frozen storage and transport of drug substance between bulk fill and final fill is commonplace, and there’s never been a greater need to understand this critical step in the manufacturing process. Download this white paper from Pall to learn more about static or blast freezing and plate freezing, how cryoconcentration affects your drug substance and how to control freezing kinetics to maintain the homogeneity of your product.
Subscribe to our FREE newsletter